ANDA 208589, held by Pai Holdings Pharm. Clobetasol Propionate.
As of Nov 16, 2026, ANDA 208589 (Clobetasol Propionate), held by Pai Holdings Pharm, was first approved by FDA on Jan 23, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 23, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clobetasol Propionate0.05% ยท ointment;topical | Clobetasol Propionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters